Results 141 to 150 of about 664,100 (294)

A peculiar case of primary lymphoma of pancreas: A rare presentation of Hodgkin lymphoma. [PDF]

open access: yesOncoscience
Mohiuddin O   +5 more
europepmc   +1 more source

Bispecific Nanosystems Enable Multieffector Immune Cell Retargeting for Hematologic Malignancy Therapy

open access: yesAdvanced Science, EarlyView.
B‐cell lymphomas are aggressive malignancies with limited treatment options. A bispecific nanosystem (biHSNPs) is developed, leveraging silica nanoplatforms to conjugate antibodies targeting immune effector cells and B‐cell antigens. biHSNPs form artificial immunological synapses, activating cytotoxic responses and suppressing tumor proliferation. This
Yefeng Shen   +12 more
wiley   +1 more source

Faecalibaculum rodentium Alleviates Ionizing Radiation‐Induced Damage in Mice by Improving Intestinal Integrity and Hematopoiesis via Its Metabolite Butyrate

open access: yesAdvanced Science, EarlyView.
The model shows the probiotics screening and underlying mechanisms of F. rodentiumn in alleviating IR‐induced tissue injury. Stress‐induced STAT3 mitochondria localization decreases F. rodentium abundance and butyrate concentration. Supplementation of F.
Hanyong Zhu   +17 more
wiley   +1 more source

PB2101: A PROSPECTIVE INVESTIGATION INTO THE TIMING AND STATUS OF BCMA-CART IN SECONDARY PLASMA CELL LEUKEMIA

open access: yesHemaSphere, 2023
Yuelu Guo   +11 more
doaj   +1 more source

Dihydrofolate Reductase from a Resistant Subline of the L1210 Lymphoma

open access: hybrid, 1967
John P. Perkins   +2 more
openalex   +1 more source

Procyanidin B3 and Its Derivatives Alleviate Neuronal Injury by Targeting G3BP1 for Ischemic Stroke Therapy

open access: yesAdvanced Science, EarlyView.
Ischemic stroke is a serious disease with high rates of mortality and disability, but there is a lack of novel therapeutic targets and agents for it. Now it is shown that Ras GTPase‐activating protein SH3 domain‐binding protein 1 (G3BP1) has the potential to serve as a therapeutic target for ischemic stroke.
Heyanhao Zhang   +10 more
wiley   +1 more source

A prospective study of prophylactic dexamethasone with glofitamab in relapsed/refractory large B-cell lymphoma

open access: yesBlood Neoplasia
J. Erika Haydu   +27 more
doaj   +1 more source

P1173: EARLY ADMINISTRATION OF POLATUZUMAB VEDOTIN AS BRIDGING CD19-SPECIFIC CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY IS AN EFFECTIVE STRATEGY TO IMPROVE SURVIVAL IN PATIENTS WITH R/R B-CELL LYMPHOMA

open access: yesHemaSphere, 2023
Fan Yang   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy